437 related articles for article (PubMed ID: 19266566)
21. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
22. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
23. Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.
Orlando A; Mocciaro F; Renna S; Scimeca D; Rispo A; Lia Scribano M; Testa A; Aratari A; Bossa F; Tambasco R; Angelucci E; Onali S; Cappello M; Fries W; D'Incà R; Martinato M; Castiglione F; Papi C; Annese V; Gionchetti P; Rizzello F; Vernia P; Biancone L; Kohn A; Cottone M
J Crohns Colitis; 2014 Oct; 8(10):1217-21. PubMed ID: 24630485
[TBL] [Abstract][Full Text] [Related]
24. "In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease.
Cossu A; Biancone L; Ascolani M; Pallone F; Boirivant M
J Crohns Colitis; 2013 Jul; 7(6):441-50. PubMed ID: 22840925
[TBL] [Abstract][Full Text] [Related]
25. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
26. [Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
Karoui S; Kallel L; Boubaker J; Filali A
Tunis Med; 2006 Oct; 84(10):595-8. PubMed ID: 17193847
[TBL] [Abstract][Full Text] [Related]
27. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA
Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
[TBL] [Abstract][Full Text] [Related]
28. Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients.
Diamanti A; Basso MS; Gambarara M; Papadatou B; Bracci F; Noto C; Castro M
Int J Colorectal Dis; 2009 Jan; 24(1):19-25. PubMed ID: 18797887
[TBL] [Abstract][Full Text] [Related]
29. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
[TBL] [Abstract][Full Text] [Related]
30. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
[No Abstract] [Full Text] [Related]
31. Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.
Schwartz M; Regueiro M
Curr Gastroenterol Rep; 2011 Feb; 13(1):95-100. PubMed ID: 21042888
[TBL] [Abstract][Full Text] [Related]
32. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
[TBL] [Abstract][Full Text] [Related]
33. Prevention of postoperative recurrence of Crohn's disease by infliximab.
Sorrentino D; Terrosu G; Avellini C; Beltrami CA; Bresadola V; Toso F
Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):457-9. PubMed ID: 16538123
[TBL] [Abstract][Full Text] [Related]
34. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
[TBL] [Abstract][Full Text] [Related]
35. Impact of capsule endoscopy on prevention of postoperative recurrence of Crohn's disease.
Han ZM; Qiao WG; Ai XY; Li AM; Chen ZY; Feng XC; Zhang J; Wan TM; Xu ZM; Bai Y; Li MS; Liu SD; Zhi FC
Gastrointest Endosc; 2018 Jun; 87(6):1489-1498. PubMed ID: 29355520
[TBL] [Abstract][Full Text] [Related]
36. Prevention of recurrence after surgery for Crohn's disease: efficacy of infliximab.
Yamamoto T
World J Gastroenterol; 2010 Nov; 16(43):5405-10. PubMed ID: 21086556
[TBL] [Abstract][Full Text] [Related]
37. Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.
Kotze PG; Yamamoto T; Danese S; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; de Barcelos IF; da Silva RN; da Silva Kotze LM; Olandoski M; Sacchi M; Yamada A; Takeuchi K; Spinelli A
J Crohns Colitis; 2015 Jul; 9(7):541-7. PubMed ID: 25820017
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn's disease.
Yuksel I; Kilincalp S; Coskun Y; Akinci H; Hamamci M; Alkan A
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):809-816. PubMed ID: 31094855
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting.
Allocca M; Landi R; Bonovas S; Fiorino G; Papa A; Spinelli A; Furfaro F; Peyrin-Biroulet L; Armuzzi A; Danese S
Digestion; 2017; 96(3):166-172. PubMed ID: 28903094
[TBL] [Abstract][Full Text] [Related]
40. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
